Internal Medicine, Endocrinology, Diabetes, & Metabolism · Albuquerque, NM
NPI
1386088433
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Msc10 5550 1 University of New Mexico
Albuquerque, NM, 87131
Phone (505) 272-4657
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
171 services
Medicare patients, 2024
96
Average age 67
Drug cost, 2024
$727K
756 prescriptions
Company payments, 2025
$402
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kristen M Gonzales was code 99214 (office e&m - established), 75 times for 56 patients. In total Kristen M Gonzales billed 171 services in 12 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 75 | 56 | $71.32 | $5,349 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 27 | 26 | $13.08 | $353 |
| 99204 Office E&M - New | Facility | 13 | 13 | $93.27 | $1,212 |
By year: 2022 $18K for 225 services; 2023 $13K for 173 services; 2024 $10K for 171 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kristen M Gonzales prescribed most often to Medicare patients was Levothyroxine Sodium, with 79 prescriptions and refills. In total Kristen M Gonzales wrote 756 Medicare prescriptions that cost $727K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 79 | 213 | 24 | $1,347 |
| Mounjaro Tirzepatide | 79 | 90 | 20 | $93K |
| Ozempic Semaglutide | 64 | 74 | 18 | $63K |
| Testosterone Generic | 35 | 38 | Under 11 | $3,576 |
| Hydrocortisone Generic | 35 | 58 | Under 11 | $1,272 |
| Alendronate Sodium Generic | 27 | 76 | 11 | $241 |
| Metformin Hcl Er Metformin Hcl | 27 | 49 | 11 | $341 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 23 | 37 | Under 11 | $2,096 |
| Novolog Flexpen Insulin Aspart | 18 | 37 | Under 11 | $3,744 |
| Methimazole Generic | 17 | 36 | Under 11 | $63.26 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 16 | 22 | Under 11 | $886 |
| Cabergoline Generic | 16 | 21 | Under 11 | $471 |
| Rosuvastatin Calcium Generic | 15 | 39 | Under 11 | $153 |
| Tresiba Flextouch U-100 Insulin Degludec | 14 | 14 | Under 11 | $6,802 |
| Novolog Insulin Aspart | 13 | 14 | Under 11 | $1,869 |
Brand drugs: 363 claims; generic drugs: 353 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kristen M Gonzales $402 ($402 in general payments such as food, travel and fees) from 3 companies. The largest payer was Corcept Therapeutics with $183.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.